Alemtuzumab biosimilar(BioXpress) | m-entrepreneurship.com

Product Name :
Alemtuzumab biosimilar(BioXpress)

Search keywords :
Alemtuzumab

drugId :
null

Target Vo:
CAMPATH-1 antigen

Target Vo Short Name :
CD52

Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bioxpress Therapeutics Sa

Active Company_Name :
Bioxpress Therapeutics Sa

Active Indication_Name:
Leukemia, B-Cell

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Romosozumab Epigenetic Reader Domain
LRP1 Rabbit mAb Data Sheet
IFN gamma Antibody: IFN gamma Antibody is an unconjugated, approximately 15 kDa, rabbit-derived, anti-IFN gamma polyclonal antibody. IFN gamma Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, background without labeling.

Author: Betaine hydrochloride

Related Posts